Chaotic, Disorganized, and Mismanaged - Recensione dipendente - Scientist presso Zymeworks

1,0
27 mag 2022
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Zanidatamab is an excellent asset

Svantaggi

- Talented & experienced group of scientists that developed Zanidatamab are no longer at Zymeworks - Senior Scientific leadership does not have the necessary drug development experience - Success of pipeline projects doesn't matter, company is treading water to get to a sale - CEO has no history developing medicine or building companies. His history is dominated by breaking apart and selling assets. - Former CFO, at least partly responsible for the cratering of the company, is allowed to remain and transition to COO. - Company still talks about its values as though they determine corporate behavior

Esplora altre recensioni su Zymeworks

5,0
15 gen 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good discipline nice work experience

Svantaggi

No bad experience it was good

4,0
10 apr 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good mangement okay salary good

Svantaggi

Nothing to say from me

Vedi recensioni per: Utile|Valutazione|Data|Tutto